EGFR and glioblastoma: In contrast, the EGFR/SRC/ERK signaling pathway can phosphorylate and stabilize the m6A reader protein YTHDF2, which is necessary to sustain the invasive, proliferative, and tumorigenic properties of glioblastomas [34].